Licensing Terms. 10.1 You may as a program participant access to certain software, development tools (SDK), or API (herein the “ Alcatel-Lucent Enterprise Materials”), by downloading such materials from this web site, and by ordering by the means of the DSPP, either with no additional charge or subject to a license fee. Subject to the terms and conditions accompanying such materials or set forth on the DSPP website in respect of such Alcatel-Lucent Enterprise Materials, which shall prevail over these terms in case of discrepancy, Your use of the Alcatel- Lucent Enterprise Materials is governed by this Agreement including this Article 10.
10.2 The license on the Alcatel-Lucent Enterprise Materials (i.e.: right of use) is a non-exclusive and non- transferable license to use the Alcatel-Lucent Enterprise Materials in object code or text form, for use up to the licensed number of users, and only on the system for which they were designed, and solely for Development Purpose and not for redistribution or sublicensing (“License”). In this Agreement “Development Purpose” shall mean the use of the Alcatel-Lucent Enterprise Materials to evaluate or ensure the inter-working of Your Application with the Alcatel-Lucent Enterprise Platforms. The License is granted for the Term of this Agreement, or any other term mentioned for the relevant Alcatel-Lucent Enterprise Materials in the documentation accompanying such materials, or on the DSPP website. You shall (i) not sublicense, transfer, sell or otherwise communicate or make available the Alcatel-Lucent Enterprise Materials to third parties and shall protect and secure them using the same degree of care You use to protect Your own proprietary rights, but in any case not less than reasonable care, (ii) not modify the Alcatel-Lucent Enterprise Materials in whole or in part, except as authorized hereunder for Development Purpose and (iii) not reverse assemble, or decompile the Alcatel-Lucent Enterprise Materials in whole or in part, except as explicitly provided by law. In particular, the use of information elements issued from interfaces of the Alcatel-Lucent Enterprise Platform and Alcatel-Lucent Enterprise Materials not authorized for use through DSPP are prohibited (reverse engineering is not allowed). This License shall in no event be construed as being a sale of intellectual property rights, a sale of a copy of a program, or a transfer of ownership of the rights in the Alcatel-Lucent Enterprise Materials. Notwithstanding the foregoing...
Licensing Terms. COMPANY shall have complete and sole discretion regarding the terms, conditions and pricing of Images licensed or sublicensed to third parties. COMPANY shall have complete and sole discretion as to delivery methods and distribution of the Images, including without limitation, single image download, multiple Image disc or other pricing method.
Licensing Terms. Solution Provider shall have a temporary, free of charge, non-exclusive and non-transferable right and license to execute, reproduce and display the Non-GA Program specifically designated in the corresponding PID for a given AP and listed in the corresponding RFL(s) duly accepted by DS, in Object Code form, and to utilize, in support thereof, any associated Documentation and other information which may be provided by DS. The duration of such license shall be provided for in the corresponding RFL(s) and shall not exceed three (3) months. In addition, due to the Non-GA nature of the Program(s), DS shall be entitled, at any time, to terminate this license as of right and without legal proceedings, immediately upon receipt of a written notice to that effect. Solution Provider will have the right to use the Non-GA Program(s) only for its own internal evaluation purposes within the frame of the corresponding PID, on the sole Designated Machine(s) located at Solution Provider's Site and identified in the corresponding RFL, expressly excluding any commercial or general production purposes. 19 CATIA V5 GALAXY PROGRAM SOLUTION PROVIDER AGREEMENT
Licensing Terms. You agree that You will not copy, modify, adapt, enhance, translate or create a derivative work of the Mobile Payment Service or any part of the Service. You will not license, sublicense, market or distribute the Mobile Payment Service, or provide any copies to a Third Party. You will not attempt to reverse engineer, decompile, disassemble or make error corrections to any part of the Mobile Payment Service, and You will not use any part of the Mobile Payment Service to gain access to interconnecting software applications to do the same.
Licensing Terms. Center Members may request a non-exclusive, royalty-free, non-transferable, research and development license to make, have made, and use in its own facilities any patented or patent pending inventions supported, in whole or in part, by dues-funded research projects reported to the Center upon payment of their proportional share of patent expenses. (See Section 4.9
Licensing Terms. Organisations that license your content via NMN will have the right to exhibit (broadcast/communicate to the public) your materials, in all media (whether now known or hereafter devised) throughout the world in perpetuity or on a limited term depended on our license agreement. This also allows third parties to do the same when approved by NMN. - Credit will be requested for most online & print media. - An example of content credit appears below; “Xxxxx Xxxxx / Severe Weather Australia” “Xxxxx Xxxxx / News Media Network” - Credit information is supplied in your (Your Full Name) entry via our submission form. - Should you wish to not be publicly credited for your work, use the following example: Your Full Name = “Xxxxx Xxxxx – PLEASE DO NOT CREDIT ME” - Note: Credit is not required for television broadcasters or subsequent website and/or social media use. - Errors may be made by a Publisher/Client, we will do our best to correct any error brought to our attention. Please email xxxx@xxxxxxxxx.xxx.xx regarding any credit error and forward links/evidence for what needs updating.
Licensing Terms. 5.3.1 For the period beginning on the Closing Date until the second anniversary of the Closing Date:
(a) For any Maxygen Other Improvement for which a patent application and/or patent claims priority to a date during this period, Maxygen agrees to grant and agrees to cause its Affiliates to grant, and hereby grants, to Bayer a fully-paid, non-exclusive license, with the right to sublicense to its Affiliates, under Patents Rights Controlled by Maxygen and/or any of its Affiliates claiming such Maxygen Other Improvement, for any Permitted Use, other than uses in the Maxygen Field, in the Territory.
(b) For any Bayer Other Improvement for which a patent application and/or patent claims priority to a date during this period, Bayer agrees to grant and agrees to cause its Affiliates to grant, and hereby grants, to Maxygen a fully-paid, non-exclusive license, with the right to sublicense, under Patents Rights owned and/or controlled by Bayer and/or any of its Affiliates claiming such Bayer Other Improvement, for any use in the Territory; provided Maxygen, its Affiliates, any licensees and sub-licensees shall not be entitled to use such Bayer Other Improvement in the Bayer Field.
5.3.2 For the period beginning on the second anniversary of the Closing Date and ending on the fourth anniversary of the Closing Date:
(a) For any Maxygen Other Improvement for which a patent application and/or patent claims priority to a date during this period, the Parties agree to negotiate in good faith to reach commercially reasonable financial terms for a non-exclusive license to Bayer, with the right to sublicense to its Affiliates, under Patents Rights Controlled by Maxygen and/or any of its Affiliates claiming such Maxygen Other Improvement, for any Permitted Use, other than uses in the Maxygen Field, in the Territory; and
(b) For any Bayer Other Improvement for which a patent application and/or patent claims priority to a date during this period, the Parties agree to negotiate in good faith to reach commercially reasonable financial terms for a non-exclusive license to Maxygen, with the right to sublicense, under Patents Rights owned and/or controlled by Bayer and/or any of its Affiliates claiming such Bayer Other Improvement, for any use in the Territory; provided, however, Maxygen shall not be entitled to use such Bayer Other Improvement in the Bayer Field.
(c) If the Parties cannot reach agreement on the commercially reasonable financial terms for such a license under Section...
Licensing Terms. Access to and use of Contractor’s websites shall be subject to the following terms:
a. Contractor hereby grants students enrolled in the District's school(s), the parents of such students, and teachers and school administrators employed by the District a limited, non-transferable, non- sublicensable, non-exclusive, revocable in the event of breach right during the term of this Contract to access and use Contractor’s websites solely for educational purposes.
b. All of the rights, title and interest in the Contractor’s websites (including all underlying concepts, methodologies, processes, formats, specifications, other know-how, and works derived from the websites, and all copyright, trademark and other associated intellectual property rights) other than the rights granted District in the previous sub- paragraph are reserved to Contractor and its licensors. The websites may not be used for the benefit of any third party who has not been provided a personal user identification and password by Contractor. The foregoing prohibition includes use of the websites by any unauthorized third party through the sharing of the user identification of an authorized user, reproduction or duplication of any portion of the websites and resale of access to the websites.
c. All use of Contractor’s websites by Users shall be subject to the Terms of Use which are set forth at xxx.xxxxxxx0000.xxx/xxxxx including, but not limited to, the restrictions on use set forth therein. In the event of conflict between such Terms of Use and this contract, this contract shall prevail.
Licensing Terms. The PARTIES shall agree to the marketing, distribution and licensing rights for PRODUCTS (including terms governing BACKGROUND INTELLECTUAL PROPERTY and FOREGROUND INTELLECTUAL PROPERTY embodied in such PRODUCTS). The marketing, distribution and licensing rights for existing PRODUCTS and FEATURES are set out in the SPECIFIC PRODUCT/FEATURE ADDENDA in Exhibit E. The marketing, distribution and licensing rights for future PRODUCTS and FEATURES, as agreed by the PARTIES, shall be added by addition of SPECIFIC PRODUCT/FEATURE ADDENDA to Exhibit E. If appropriate, future PRODUCTS or FEATURES shall be designated as being subject to Type A, Type B, Type C, Type D, Type E or Type F licenses. In the event that the chosen CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS. license type is a *********************** or ********************, the royalty payment and ******************* shall be set out in the corresponding SPECIFIC PRODUCT/FEATURE ADDENDUM. The current license categories shall not preclude the PARTIES from augmenting the terms of an ********************** or from creating new license types. Any such augmented or additional license type must be agreed to, in writing, by the PARTIES.
Licensing Terms. Subsection 1.1 of the Agreement shall be amended and restated to read in its entirety as follows: "The Software may be installed on an unlimited number of servers on the CDN for the sole purpose of delivering a live and/or on Video on Demand streaming service for Macromedia Flash Video (the "Service")."
